Skip to main content
IPHA logo

IPHA

Innate Pharma SA
$1.80 -0.01 (-0.55%) At close · Jul 2
Market Cap
$169.03M
Shares
93,719,323

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 9
Total Value: $235,452
Total Shares: 183,951

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 9 13F filers · Δ vs Dec 31, 2025
Top Holder
44.1%
Jun 2023 → Mar 2026 · range 33.6% – 65.6%
+10.5 pts
Top 5
99.4%
Jun 2023 → Mar 2026 · range 97.4% – 99.8%
+2.0 pts
Top 10
100.0%
Jun 2023 → Mar 2026 · range 100.0% – 100.0%
+0.0 pts
HHI
3,099
Jun 2023 → Mar 2026 · range 2,408 – 4,953
Highly concentrated+663

Quarterly Activity

vs Dec 31, 2025
New
1
Increased
0
Decreased
6
Sold Out
3
Unchanged
2
Holder count: -2
Institutional value: -51.3%
Shares held: -33.4%

Top Buyers

vs Dec 31, 2025
No qualifying movers this quarter.

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 9 of 9
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1598599 CUSIP 45781K204 Visit website Investor relations